期刊文献+

脂质体-免疫分析法测定血清总补体溶血活性及临床应用

The Determination of Serum CH_(50) with Liposome Immunoassay and its Clinical Application
下载PDF
导出
摘要 目的:探讨血清总补体溶血活性(CH50)在临床中的应用价值。并观察宣温下放置不同时间血清CH50的变化。方法:采用脂质体-免疫分析法检测50例健康成年人、14例慢性肝病患者和26例狼疮肾病患者(其中11例为活动期)血清的CH50及C3和C4含量。结果:结果表明健康成年人LIA法血清总补体溶血活性(CH50)范围为25—57U/ml。血清在宣温下放置4h后,CH50明显降低。14例慢性肝病患者CH50及C3和C4较健康者降低,其中C3、C4与CH50的相关系数为0.857和0.807。26倒狼疮肾病患者活动期与非活动期C3、C4含量无明显差异,而活动期较非活动期CH50明显降低,有极显著差异。结论:总补体溶血活性(CH50)检测,待测血清必需新鲜,宣温放置不能超过4h。脂质体-免疫分析法(LIA)检测总补体溶血活性,主要反映补体经经典途径活化的活性。补体含量及活性联舍检测对临床诊断意义更大。 Objective : To investigate the clinical applicable value of serum total complement hemolysis activity ( CH50) and to investigate the change of CH50 in different time in room temperature after serum being collected. Methods: CH50, C3 and C4 were quantitated in sera from 50 healthy volunteers, 14 patients with chronic liver disease and 26 patients with lupous nephropathy with liposome immunoassay. Results: In sera from healthy volunteers, CH50 ranged from 25 to 50U/ml and decreased significantly after being laid for 4 hours. In sera from patients with chronic liver disease, CH50, C3 and CA decreased significantly comparing to healthy volunteers and the correlation coefficient was 0. 857 and 0.807 between CH50 and C3 and between CH50 and C4 respectively. There were no significant difference between the levels of C3 and C4 in sera from patients with activity lupous nephropathy and non - activity lupous nephropathy, but there were significant difference between the CH50 in sera from patients with activity lupous nephropathy and non -activity lupous nephropathy. Conclusion: To quantitate the CH50, It is necessary to use fresh serum and the laid time is less than 4 hours in room temperature. CH50 tested by with liposome immunoassay mainly reflects complement activity of classical pathway. The combination assay of concentration and activity of complement have more value for clinical diagnosis.
出处 《河北医学》 CAS 2006年第2期97-99,共3页 Hebei Medicine
关键词 血清总补体溶血活性 脂质体-免疫分析法 补体 Serum total complement hemolytic activity Liposome immunoassay ( LIA) Complement
  • 相关文献

参考文献6

  • 1Jaskowski TD,Martins TB,Litwin CM,Hill HR.Measuring classical pathway complement activity[J].Clinical Diagnosis Lab Immunol.1999,6(1):137-139. 被引量:1
  • 2Tanaka K,Aiyama T,Imai J,Morishita Y,Fukatsu T,Kakumu S.Serum cryoglobulin and chronic hepatitis C virus disease among Japanese patients[J].AM Gastroenterol,1990(10):847-852. 被引量:1
  • 3Milis L,et al.The value of complement measurements in the assessment of lupus activity[J].1992.Aust N Z J Med,Aug,22(4):338-344. 被引量:1
  • 4Drew JH,et al.The complement system of the newborn infant[J].Bio Neonate,1980,37:209-217. 被引量:1
  • 5Yoshida H.Analyses of preanalytical issues on samplings and samples[J].Rinsho Byori,2001,49(3):211-218. 被引量:1
  • 6Souda N,et al.Studies on the conditions of blood sampling and storage for liposome-based CH50 assay[J].Rinsho Byori,1998,46(10):1049-1055. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部